GlassScriptPhysician profile
William V Sudduth
NPI 1225043730
$2,050.16
in general payments reported to CMS, 2019-2025
24 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $651 · 2023: $430 · 2024: $232 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $542.33 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, General - Tachy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $352.95 | 2021-2024 | Lifevest |
| Abbott Laboratories | $166.52 | 2023-2025 | Cardiomems, Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit |
| Amgen INC. | $116.24 | 2021-2023 | Repatha |
| Impulse Dynamics (USA) INC. | $108.74 | 2025 | Optimizer |
| Philips North America LLC | $107.70 | 2023-2024 | (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Novartis Pharmaceuticals Corporation | $68.15 | 2022-2023 | |
| Atricure, INC. | $65.78 | 2023-2025 | Atriclip Laa Exclusion System |
| E.R. Squibb & Sons, L.L.C. | $65.67 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $64.39 | 2021-2022 | |
| Medtronic, INC. | $61.24 | 2023-2025 | Mycarelink, Onyx Frontier, Corevalve Evolut R |
| Abiomed | $60.78 | 2024-2025 | Impella |
| Novo Nordisk INC | $41.90 | 2023-2024 | Rybelsus, Ozempic |
| Pfizer INC. | $41.18 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $36.44 | 2022-2025 | Verquvo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.38 | 2022 | |
| Irhythm Technologies, INC. | $24.59 | 2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $16.50 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $15.66 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.28 | 2021 | |
| Cardiva Medical, INC. | $13.93 | 2023 | Cardiva Vascade 6/7f Vcs |
| Janssen Pharmaceuticals, INC | $12.80 | 2021 | |
| Lundbeck LLC | $12.17 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sudduth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.